Venetoclax with azacitidine combination shown 91 percent response rate among older adults who were newly diagnosed with acute myeloid leukemia (AML), from Latest Drug News https://ift.tt/2BDqSjk
No comments
Thanks for comment via will connect you within 24 hours.